Abstract
Thiamine (vitamin B1), cofactor for various multi-enzyme complexes in energy metabolism, and plays a major role in the synthesis of cholinesterases such as acetylcholinesterase (AChE); butyrylcholinesterase (BChE). Present study deals with the changes in the cholinesterases, γ-aminobutyric acid (GABA) and serotonin in mice brain following thiamine deficiency. Experimental mice (6–8 week old) were made thiamine deficient by intraperitoneal injection of pyrithiamine hydrobromide and fed with thiamine-deficient diet. Animals were divided into three groups, Group I (Control), Group II (thiamine deficient mice for 8 days), and Group III (thiamine deficient mice for 10 days). The higher serotonin level whereas significant decreases in the AChE, BChE and GABA level were recorded in treated groups as compared to control. Hence, vitamin B1 deficiency disturbs the cholinergic system and neurotransmitters levels in brain which may lead to neurodegenerative diseases.
Öz
Tiamin (vitamin B1), enerji metabolizmasında çeşitli multi-enzim kompleksleri için kofaktör ve Asetilkolinesteraz (AChE), Butirilkolinesteraz (BChE) gibi kolinesterazların sentezinde önemli bir rol oynar; Bu çalışma tiamin eksikliğini takiben farelerde beyindeki kolinesteraz, γ-aminobütirik asit (GABA) ve serotonin değişikliklerini ele almaktadır. Deney fareleri (6–8 haftalık) intraperitoneal pitmiamin hidrobromür enjeksiyonu ile tiyamin eksikliği yapıldı ve tiamin eksikliği olan diyetle beslendi. Hayvanlar 3 gruba ayrıldı, Grup I (Kontrol), Grup II (8 gün boyunca tiamin eksikliği olan fareler) ve Grup III (10 gün boyunca tiamin eksikli fareler). Kontrol grubuna kıyasla tedavi edilen gruplarda daha yüksek serotonin seviyesi, AChE, BChE ve GABA seviyesinde önemli düşüşler kaydedildi. Bu nedenle, B1 vitamini eksikliği, nörodejeneratif hastalıklara yol açabilen beyin içindeki kolinerjik sistemi ve nörotransmiter seviyelerini bozabilir.
Introduction
Thiamine, an essential vital water soluble vitamin which is required continuously in daily dietary intake to support as a cofactor for several multi enzyme complex of carbohydrate metabolism [1]. It also plays a major role in the synthesis of acetylcholinesterase (AChE). Breads, fish, legumes, meat and eggs are the sources of thiamine [2]. The recommended dietary intake of thiamine for men and women is in the range of 1–1.5 mg/day approximately. Cholinergic system in brain involved in memory and learning. Any alteration in cholinergic system affects the metabolism of brain and causes neurodegenerative diseases such as Alzheimer’s disease [3]. There are two types of cholinergic enzymes namely acetylcholinestrases and butyrylcholinestrases (BChE) were found in brain and function of AChE and BChE is to terminate the action of acetylcholine and butyrylcholine in nerve terminals [4]. AChE is a key enzyme plays a important function in nervous system [5]. It catalyzes the acetylcholine at synaptic cleft to transmit the nerve signal from one neuron to another. The activity of AChE and BChE are in with synergistic relationship to maintain the cholinergic function. Therefore, alteration in AChE activity directly affects the level of BChE in the body [6]. Inhibition of AChE and BChE can act as a biomarker for several diseases [7].
In addition, γ-aminobutyric acid (GABA) and serotonin are neurotransmitters found in brain. GABA is a major inhibitory neurotransmitter and produced from glutamic acid. It reduces neuronal excitability which helps in dropping down the anxiety and pain. Serotonin is a biogenic amine and excitatory neurotransmitter of the body. Only 1–2% of the total serotonin is found in brain. It rapidly elevates O2− formation in pulmonary artery smooth muscle cells and its metabolites are aptly to enhance plasma lipid peroxidation via changes in the redox potential. Enhancement of serotonin level promotes oxidative stress [8] which is one of the key features of neurodegernative diseases caused due to thiamine deficiency [1]. Hence, present study was designed to observe the effect of thiamine deficiency on cholinesterases (AChE; BChE), GABA and serotonin level in mice.
Materials and methods
Chemicals
Pyrithiamine hydrobromide and acetylthiocholine iodide were purchased from Sigma (MO, USA). 5,5′-Dithiobis-2-nitrobenzoic acid, (DTNB), butyrylthiocholine iodide, EDTA, tris hydrochloride, trichloroacetic acid (TCA), formaldehyde, ethanol and pure wax were purchased from Sisco Research Laboratories (Mumbai, India). All other chemicals were of analytical grade.
Animal care and monitoring
Healthy Mus musculus (6–8 week old) were procured from C.C.S. Haryana Agricultural University, Hissar. They were fed with pelleted diet (Hindustan Uniliver Limited, Mumbai, India) and water ad libitum. After 3–7 days of familiarization, mice were used for experimental purpose. Maintenance and treatment of animal were done in accordance with the Committee for the Purpose of Control and Supervision of Experimentation on Animals (CPCSEA).
Experimental design
The animals were divided into three groups having six animals in each group.
Group I Normal pelleted diet+normal saline |
Group II Thiamine deficient diet+pyrithiamine exposed for 8 days |
Group III Thiamine deficient diet+pyrithiamine exposed for 10 days |
Induction of thiamine deficiency (TD)
Mice were made thiamine deficient by injecting the pyrithiamine hydrobromide (5 μg/10 g of body weight) intraperitoneally and fed with thiamine deficient pelleted diet. Control animals were fed with normal diet.
Biochemical studies
Sample preparation for AChE and BChE
After the treatment, experimental mice were sacrificed by cervical dislocation. Brains were removed and washed with normal saline. The tissues were homogenized in the specific buffer (0.1 M phosphate buffer) and centrifuged at 1200 g for 10 min at 4°C. Further, supernatant was used for biochemical analysis of AChE and BChE.
Acetylcholinesterase (AChE)
AChE releases thiocholine from acetylcholine which reacts with the DTNB, reducing it to the thiol which has an absorption maximum at 412 nm. The activity of AChE was assayed by the method of Ellman et al. [9]. Protein was measured by the method given by Lowry et al. [10]. The activity of AChE enzyme was expressed in terms of nmol/mg of protein/min.
Butyrylcholinesterase (BChE)
Ellman et al. [9] method was used for determination of BChE activity. BChE releases thiocholine from butyrylcholine and reacts with DTNB reduced into thiol which shows maximum absorption at 412 nm. Results were expressed as nmol/mg of protein/min.
γ-Aminobutyric acid (GABA) content
The level of GABA was measured in aliquots of the perchlorate free extract [11]. The reaction mixture contains 400 μL of extract (sample), 100 μL of 2-mercaptoethanol, 100 μL of NADP, 100 μL of α-ketoglutarate, 250 μL of buffer and 50 μL of Gabase. Samples were mixed and read at 340 nm. Results were expressed in terms of μg GABA/g of tissue weight.
Serotonin level
Brains were removed and washed in normal saline. The tissues (300 mg) were weighed and homogenized in 3 mL of borate buffer (pH 10) saturated with n-butanol. Serotonin was extracted from the tissue. In the extract, 1 mL of nitroso napthol and 1 mL of nitrous reagent were added. The extract was incubated on waterbath for 5 min at 55°C. Dichloroethane was added in the samples and shaken properly. Samples were centrifuged at 3000 rpm for 10 min at 4°C. Absorbance of the aqueous phase was measured at 540 nm [12]. Results were expressed as of μg serotonin/g of tissue weight.
Statistical analysis
Results were expressed as mean±SE. Data of present investigation was statistically analyzed by one-way analysis of variance (ANOVA) using (SPSS 16.0). Inter group comparison was made by using Tukey’s test.
Effect of TD on neurotransmitters level in brain homogenate of Mus musculus
Effect on AChE (Figure 1)
Data of the current study showed that significantly lower AChE activity was determined in treated groups which were made thiamine deficient for 8 (p<0.05) and 10 days (p<0.0001) with respect to control group. As compared to group II, decline AChE activity was observed in group III. Among treated and non-treated groups, AChE activity was found to be lower in group III.

AChE levels in brain of different experimental groups. Results were expressed in mean ± SE. (a) compared to group I; (b) compared to group II; (c) compared to group III. *p<0.05, ****p<0.0001.
Effect on BChE (Figure 2)
As consequences of TD, the activity of BChE was altered in different experimental groups. When compared to control group, decline in BChE activity was recorded in group II. In treated group III, BChE activity was significantly decreased (p<0.05) with respect to control group. Thus, it was explained from Figure 2 that the maximum reduction in BChE activity was found to be in group III with respect to other groups.

BChE levels in brain of different experimental groups. Results were expressed in mean±SE. (a) compared to group I; (c) compared to group III. *p<0.05.
Effect on GABA content (Figure 3)
A significant reduction in the level of GABA was observed in group II (p<0.05) and group III (p<0.0001) as compared to group I. In comparison with group II, decreased content of GABA was recorded in group III (p<0.01). Among all the groups, lower GABA content was observed in the group III

GABA content in brain of different experimental groups. Results were expressed in mean±SE. (a) compared to group I; (b) compared to group II; (c) compared to group III. *p<0.05, **p<0.01, ****p<0.0001.
Effect on serotonin level (Figure 4)
Serotonin content was found to be successively increased in treated groups. A significant rise (p<0.0001) in the echelon of serotonin was recorded in treated groups (groups II and III) as compared to control group. Also, significantly higher (p<0.0001) serotonin content was found in group III with respect to group I and group II.

Serotonin content in brain of different experimental groups. Results were expressed in mean±SE. (a) compared to group I; (b) compared to group II; (c) compared to group III. ****p<0.0001.
Discussion
Brain is a fascinating director which coordinates and regulates different organ systems in the body. Experimental TD is a classical model of a nutritional deficit associated with an impairment of oxidative metabolism and selective cell damage in the brain [13]. Thiamine serves as a specific cofactor of certain enzymes involved in energy metabolism of cells. These enzymes play pivotal role in the synthesis of number of cell constituents including neurotransmitters and production of reducing equivalent used in oxidative stress defense system [14].
Thiamine deficiency induces oxidative stress in brain and adversely affects its functions. It can act as a free radical scavenger [1]. In the present study, thiamine deficiency leads to reduction in AChE and BChE activity in brains of mice. Decline in AChE may be explained due to a direct or indirect inhibition of the central and peripheral cholinergic neurotransmitter system by sub-acute and acute deprivation of thiamine [6]. AChE plays a key role in cholinergic neurotransmission [15]. It is an important enzyme which regulates the effects of acetylcholine at cholinergic synapses. Under stress condition developed due to thiamine deficiency, AChE activity is inhibited which further interrupt the acetylcholine cleavage activity. Current study was also supported with previous research carried out by Pires et al. [16] reported diminution in AChE activity in different regions of thaimine deficient brain.
The results of current research showed declined BChE activity in thiamine deficient groups exposed for 8 and 10 days as compared to control. It also inactivates the neurotransmitter acetylcholine and therefore it is a viable therapeutic target against neurological disorders [17]. However, BChE is less efficient in ACh hydrolysis at low amount, but more efficient at higher concentrations [18]. Bist and Bhatt [4] enlightened the spatial relationship of glial BChE, which would permit BChE mediated synergistic hydrolysis of acetylcholine to allow the maintenance of normal cholinergic functions in the brain. In rat brain, lower AChE activity was recorded under stress conditions given by Ramkumar et al. [19] and Shankaranarayana et al. [20]. Hence, a possible role of BChE is when it is associated with glia cells and helps in hydrolysis of acetylcholine. Under the conditions of higher BChE activity in brain, local synaptic acetylcholine can reach at micromolar levels. Current study evaluated the reduced activity of BChE in comparison with AChE activity in brain because it was also seen by previous study that BChE concentration was about one tenth of AChE in brain [21].
Further, GABA plays a chief role in neuronal development and communication. The result of present study showed decreased level of GABA in brain of thiamine deficient mice as compared to control one. This could be due to the inhibition of GAD following the local formation of 2 keto-4-pentenoic acid. Since GABA is a vital inhibitory neurotransmitter in the CNS, therefore, it possibly may block the transmission of nerve impulse, which prevents over stimulation of the nerve cells. GABA is degraded through the GABA shunt, operating in both neurons and astrocytes to allow the carbon skeleton of GABA to re-enter the TCA cycle as succinate [22], [23]. Therefore, any alteration in TCA cycle affects the level of GABA in brain. Thiamine deficiency alters the activities of TCA cycle enzymes reported by Sharma et al. [24]. Bist and Bhatt [8] observed reduction in GABA content of brain of lindane intoxicated mice. In Schizophrenic patients, reduction of α-ketoglutarate dehydrogenase complex (KGDHC) activity may be related with an increase in the GABA content [25], [26], [27]. Batra and Seth [28] elucidated that decrease in GABA under stress may be due to altered metabolism of GABA synthesis. Alteration in GABA metabolism is associated with various neurodegenerative disorders such as epilepsy, algesia, anxiety, Parkinsonism and Huntington’s diseases [29], [30]. In Experimental TD in PTD model, decreases in thalamic GABA levels was also reported [31].
Additionally, present study elucidated that deprivation of thiamine perturbs the serotonin level of mice brain. The higher serotonin level was observed in treated groups as compared to control. This could be due to the unavailability of serotonin receptors in brain. As brain has high lipid content, it acts as a chief target of γ-HCH and solubilize the pre and postsynaptic elements. The unavailability of receptors enhances the serotonin concentration in brain which will finally lead to production of free radicals. The increased serotonin level promotes LPO in brain was elucidated previously [8], [32]. Lee et al. [33] noted that increase in serotonin rapidly elevates the level of superoxide radicals in pulmonary artery smooth muscles. 5-HT neurons in thiamine deficient conditions remain intact structurally but function of 5-HT get affected during the progression of thiamine deficiency. This alteration may be part of adaptive neuronal alteration subsequent to thiamine dysfunction which may a leading cause of neurodegenerative diseases [34].
Conclusion
Hence, the current study concluded that thiamine deficiency reduces the activities of AChE and BChE, GABA level whereas higher serotonin level in Swiss albino mice which may leads to neurodegenerative disorders.
Funding source: Indian Council of Medical Research
Award Identifier / Grant number: 2011-11080
Funding statement: Authors are thankful to Prof. Aditya Shastri, Vice-Chancellor, Banasthali University Rajasthan for providing the suitable facilities to carry out the present investigation in Department of Bioscience and Biotechnology and Indian council of medical research (ICMR), New Delhi for financial support (Funder Id: 10.13039/501100001411, 2011-11080).
References
1. Sharma A, Bist R, Bubber P. Thiamine deficiency induces oxidative stress in brain mitochondria of Mus musculus. J Physiol Biochem 2013;69:539–46.10.1007/s13105-013-0242-ySearch in Google Scholar
2. Zastre JA, Sweet RL, Hanberry BS, Ye S. Linking vitamin B1 with cancer cell metabolism. Cancer Metabol 2013;1:16.10.1186/2049-3002-1-16Search in Google Scholar
3. Shah D, Blockx I, Guns PJ, De Deyn PP, Van Dam D, Jonckers E, et al. Acute modulation of the cholinergic system in the mouse brain detected by pharmacological resting-state functional MRI. Neuroimage 2015;109:151–9.10.1016/j.neuroimage.2015.01.009Search in Google Scholar
4. Narvaez C, Ríos JM, Píriz G, Sanchez-Hernandez JC, Sabat, P. Subchronic exposure to chlorpyrifos affects energy expenditure and detoxification capacity in juvenile Japanese quails. Chemosphere 2016;144:775–84.10.1016/j.chemosphere.2015.09.060Search in Google Scholar
5. Bist R, Bhatt DK. Augmentation of cholinesterases and ATPase activities in the cerebellum and pons-medulla oblongata, by a combination of antioxidants (resveratrol, ascorbic acid, alpha-lipoic acid and vitamin E), in acutely lindane intoxicated mice. J Neurol Sci 2010;296:83–7.10.1016/j.jns.2010.05.025Search in Google Scholar
6. Sharma A, Bist R. Thiamine deprivation disturbs cholinergic system and oxidative stress in liver of Mus musculus. Int J Pharma Pharma Sci 2014;6:139–43.Search in Google Scholar
7. Auon M, Mahmood F, Khan A, Hussain R. Testicular and genotoxic effects induced by subchronic oral administration of chlorpyrifos in Japanese quail (Coturnix japonica). Pak J Agric Sci 2014;51:1005.Search in Google Scholar
8. Bist R, Bhatt DK. The evaluation of effect of alpha-lipoic acid and vitamin E on the lipid peroxidation, gamma-amino butyric acid and serotonin level in the brain of mice (Mus musculus) acutely intoxicated with lindane. J Neurol Sci 2009;276:99–102.10.1016/j.jns.2008.09.008Search in Google Scholar
9. Ellman GL, Courtney KD, Andres V, Jr., Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.10.1016/0006-2952(61)90145-9Search in Google Scholar
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. The original method for protein estimation. Biol Chem 1951:1951;193–265.10.1016/S0021-9258(19)52451-6Search in Google Scholar
11. Graham LT, Aprison MH. Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods. Anal Biochem 1966;15:487–97.10.1016/0003-2697(66)90110-2Search in Google Scholar
12. Udenfriend S, Weissbach H, Clark CT. The estimation of 5-hydroxytryptamine (serotonin) in biological tissues. J Biol Chem 1955;215:337–44.10.1016/S0021-9258(18)66041-7Search in Google Scholar
13. Karuppagounder SS, Gibson GE. Thiamine deficiency: a model of metabolic encephalopathy and of selective neuronal vulnerability. In: McCandless DW, editor. Metabolic encephalopathy. New York: Springer, 2008;235–60.10.1007/978-0-387-79112-8_12Search in Google Scholar
14. Dror V, Eliash V, Rehavi M, Assaf Y, Biton IE, Fattal-Valeyski A. Neurodegeneration in thiamine deficient rats – a longitudinal MRI study. Brain Res 2010;1308:176–84.10.1016/j.brainres.2009.10.032Search in Google Scholar
15. Kaur G, Arora SK. Acetylcholinesterase and Na+, K (+)-ATPase activities in different regions of rat brain during insulin-induced hypoglycemia. Mol Chem Neuropathol 1994;21: 83–93.10.1007/BF03160087Search in Google Scholar
16. Pires RG, Pereira SR, Pittella JE, Franco GC, Carmencita LM, Fernandes PA, et al. The contribution of mild thiamine deficiency and ethanol consumption to central cholinergic parameter dysfunction and rats’ open-field performance impairment. Pharmacol Biochem Behav 2001;70:227–35.10.1016/S0091-3057(01)00593-7Search in Google Scholar
17. Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent. Proc Natl Acad Sci USA 2005;102:17213–8.10.1073/pnas.0508575102Search in Google Scholar PubMed PubMed Central
18. Silver A. The biology of cholinesterases. New York: Elsevier/Agricultural Research Council Institute, 1974;426–47.Search in Google Scholar
19. Ramkumar K, Srikumar BN, Shankaranarayana Rao BS, Raju TS. Self-stimulation rewarding experience restores stress-induced CA3 dendritic atrophy, spatial memory deficits and alterations in the levels of neurotransmitters in the hippocampus. Neurochem Res 2008;33:1651–62.10.1007/s11064-007-9511-xSearch in Google Scholar PubMed
20. Shankaranarayana Rao BS, Raju TR, Meti BL. Self stimulation of lateral hypothalamus and ventral tegmentum increases the levels of noradrenaline, dopamine, glutamate, and AChE activity, but not 5-hydroxytryptamine and GABA levels in hippocampus and motor cortex. Neurochem Res 1998;23:1053–9.10.1023/A:1020703901794Search in Google Scholar
21. Lederis K, Livingston A. Acetylcholine and related enzymes in the neural lobe and anterior hypothalamus of the rabbit. J Physiol 1969;201:695–709.10.1113/jphysiol.1969.sp008782Search in Google Scholar PubMed PubMed Central
22. Nilsen LH, Shi Q, Gibson GE, Sonnewal U. Brain [U-13C] glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity. J Neurosci Res 2011;89: 1997–2007.10.1002/jnr.22606Search in Google Scholar PubMed PubMed Central
23. Sharma A, Bist R, Singh S. Thiamine deficiency perturbed energy metabolism enzymes in brain mitochondrial fraction of Swiss mice. Front Biol 2017;12:290–7.10.1007/s11515-017-1457-zSearch in Google Scholar
24. Kempson SA, Zhou Y, Danboltz NC. The betaine/GABA transporter and betain: roles in brain, kidney and liver. Front Physiol 2014;5:1–16.10.3389/fphys.2014.00159Search in Google Scholar PubMed PubMed Central
25. Santos SS, Gibson GE, Cooper AJ, Denton TT, Thompson CM, Bunik VI, et al. Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C] glucose and [U-13C] glutamate metabolism in cerebellar granule neurons. J Neurosci Res 2006;83:450–8.10.1002/jnr.20749Search in Google Scholar
26. Shi Q, Risa O, Sonnewald U, Gibson GE. Mild reduction in the activity of the alpha-ketoglutarate dehydrogenase complex elevates GABA shunt and glycolysis. J Neurochem 2009;109:214–21.10.1111/j.1471-4159.2009.05955.xSearch in Google Scholar
27. Bubber P, Hartounian V, Gibson GE, Blass JP. Abnormalities in the tricarboxylic acid (TCA) cycle in brain of schizophrenia patients. Eur Neuropsycho Pharmacol 2011;21:254–60.10.1016/j.euroneuro.2010.10.007Search in Google Scholar
28. Batra J, Seth PK. Effect of iron deficiency on developing rat brain. Indian J Clin Biochem 2002;17:108–14.10.1007/BF02867982Search in Google Scholar
29. Gajcy K, Lochynski S, Librowski T. A role of GABA analogues in the treatment of neurological diseases. Curr Med Chem 2010;17:2338e2347.10.2174/092986710791698549Search in Google Scholar
30. Agarwal S, Chaudhary B, Bist R. Protective propensity of bacoside A and bromelain on renal cholinesterases, γ-aminobutyric acid and serotonin level of Mus musculus intoxicated with dichlorvos. Chem Biol Interact 2017;261:139–44.10.1016/j.cbi.2016.11.027Search in Google Scholar
31. Heroux M, Butterworth RF. Reversible alterations of cerebral α-aminobutyric acid in pyrithiamine-treated rats: implications for the pathogenesis Wernicke’s encephalopathy. J Neurochem 1988;51:1221–6.10.1111/j.1471-4159.1988.tb03090.xSearch in Google Scholar
32. Aviram M, Cogan U, Modaky S. Excessive dietary tryptophan enhances plasma lipid peroxidation in rats. Atherosclerosis 1991;88:29–34.10.1016/0021-9150(91)90254-ZSearch in Google Scholar
33. Lee SL, Wang WW, Fanburg B. Superoxide as an intermediate signal for serotonin induced mitogenesis. Free Radic Biol Med 1998;24:855–8.10.1016/S0891-5849(97)00359-6Search in Google Scholar
34. Mousseau DD, Rao VL, Butterworth RF. Alterations in serotonin parameters in brain of thiamine-deficient rats are evident prior to the appearance of neurological symptoms. J Neurochem 1996;67:1113–23.10.1046/j.1471-4159.1996.67031113.xSearch in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Article
- Measurement uncertainty in laboratory medicine: the bridge between medical and industrial metrology
- Short Communication
- Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major
- Research Articles
- A practical ID-LC-MS/MS method for the most commonly analyzed steroid hormones in clinical laboratories
- Distribution of drug-metabolizing enzymes coding genes CYP2D6, CYP3A4, CYP3A5 alleles in a group of healthy Turkish population
- Molecular detection of Bacillus anthracis: evaluation of the efficiency of DNA extraction and a novel dry PCR
- Serum and cord blood-methylated arginine levels in gestational diabetic subjects
- Association of oxidative stress marker ischemia modified albumin and polycystic ovary syndrome in adolescent and young girls
- Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C
- Importance of biochemical parameters in order to predict clinical severity in patients diagnosed with Crimean-Congo haemorrhagic fever
- Evaluation of plasma VEGF and sVEGFR-1 levels in patients with diabetes mellitus receiving insulin treatment
- The effect of Ramadan fasting on renal functions in patients with chronic kidney disease
- Effect of food azo-dye tartrazine on physiological functions of pancreas and glucose homeostasis
- Ameliorating oxidative stress and inflammation by Hesperidin and vitamin E in doxorubicin induced cardiomyopathy
- Alteration in cholinesterases, γ-aminobutyric acid and serotonin level with respect to thiamine deficiency in Swiss mice
- Case Report
- Discordant troponin I value in a young woman: a case report with review of literature
- Letter to the editor
- Vitamin D test results in a public hospital in mid-January
Articles in the same Issue
- Frontmatter
- Review Article
- Measurement uncertainty in laboratory medicine: the bridge between medical and industrial metrology
- Short Communication
- Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major
- Research Articles
- A practical ID-LC-MS/MS method for the most commonly analyzed steroid hormones in clinical laboratories
- Distribution of drug-metabolizing enzymes coding genes CYP2D6, CYP3A4, CYP3A5 alleles in a group of healthy Turkish population
- Molecular detection of Bacillus anthracis: evaluation of the efficiency of DNA extraction and a novel dry PCR
- Serum and cord blood-methylated arginine levels in gestational diabetic subjects
- Association of oxidative stress marker ischemia modified albumin and polycystic ovary syndrome in adolescent and young girls
- Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C
- Importance of biochemical parameters in order to predict clinical severity in patients diagnosed with Crimean-Congo haemorrhagic fever
- Evaluation of plasma VEGF and sVEGFR-1 levels in patients with diabetes mellitus receiving insulin treatment
- The effect of Ramadan fasting on renal functions in patients with chronic kidney disease
- Effect of food azo-dye tartrazine on physiological functions of pancreas and glucose homeostasis
- Ameliorating oxidative stress and inflammation by Hesperidin and vitamin E in doxorubicin induced cardiomyopathy
- Alteration in cholinesterases, γ-aminobutyric acid and serotonin level with respect to thiamine deficiency in Swiss mice
- Case Report
- Discordant troponin I value in a young woman: a case report with review of literature
- Letter to the editor
- Vitamin D test results in a public hospital in mid-January